Abstract
Purpose To evaluate the effects of neuromuscular electrical stimulation (NMES) on physical performance, muscle strength, and body composition in patients undergoing hemodialysis. Methods Systematic searches were conducted across PubMed, Embase, Web of Science, and the Cochrane Library from their respective inceptions (earliest 1900) to March 31, 2026. Randomized and quasi-randomized controlled trials comparing NMES to usual care/sham NMES were eligible. Meta-analyses were performed for both post-intervention values and changes from baseline. Results Seventeen trials (comprising 19 reports; n = 403) were included, with NMES treatment durations ranging from 4 to 20 weeks. NMES significantly improved 6-min walk test distance in both post-intervention (MD = 43.12 m; 95% CI 18.17, 68.07) and change from baseline (MD = 37.00 m; 95% CI 11.88, 62.12) analyses. Gait speed demonstrated a significant increase in the change value analysis (MD = 0.19 m/s; 95% CI 0.10, 0.28), although post-intervention comparisons were non-significant. No significant improvements were observed in skeletal muscle mass, lean body mass, handgrip strength, or adiposity markers. NMES was well-tolerated, with no adverse effects on dialysis adequacy (Kt/V, change MD = − 0.07, 95% CI − 0.16, 0.01), electrolyte balance (e.g. potassium, change SMD = 0.14; 95% CI − 0.25, 0.53), or hemodynamic stability (e.g., systolic blood pressure, change MD = − 1.58 mmHg; 95% CI − 10.72, 7.56). Conclusion NMES is a safe and effective rehabilitative tool for enhancing exercise tolerance and functional walking capacity in patients undergoing hemodialysis, despite limited impact on muscle hypertrophy or body composition.

This publication has 61 references indexed in Scilit: